Ingredient
Hydrastis Canadensis Extract
Hydrastis Canadensis Extract is flagged for pregnancy, breastfeeding, trying to conceive and PCOS. The concern behind the strongest flag is fetal development and absorbed into the body.
- Goldenseal Extract
- Goldenseal Root Extract
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Not Recommended
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 4 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 2 of 5
- Higher means more likely to sting or redden
Hydrastis Canadensis Extract and pregnancy
Not Recommended
- Fetal development
- Absorbed into the body
- Hormone disruptor
Hydrastis Canadensis Extract, commonly known as goldenseal, contains alkaloids including berberine and hydrastine. While traditionally used as a herbal remedy, these compounds have documented pharmacological effects that extend beyond surface skin action. The primary concern during pregnancy relates to berberine, which has been shown to cross the placental barrier and may stimulate uterine contractions. Studies on oral berberine supplementation have documented effects on glucose metabolism and potential interference with fetal development. While topical absorption is lower than oral consumption, berberine can penetrate skin, particularly when the skin barrier is compromised. The alkaloid has also demonstrated effects on bilirubin metabolism, raising theoretical concerns about fetal liver development. Herbalists and midwives traditionally advised against goldenseal use during pregnancy due to concerns about uterine stimulation. ACOG does not specifically address topical goldenseal, but many obstetricians recommend avoiding berberine-containing products during pregnancy due to known systemic effects from oral consumption. The conservative approach is to avoid this ingredient when safer alternatives exist, particularly given limited safety data on topical use during pregnancy.
Hydrastis Canadensis Extract and breastfeeding
Not Recommended
- Passes into breast milk
- Infant exposure
Goldenseal extract contains berberine, an alkaloid that can be absorbed through skin and potentially pass into breast milk. Berberine is lipophilic, meaning it can accumulate in fatty tissues including breast milk. The primary concern for breastfeeding relates to berberine's effects on infant bilirubin metabolism. Berberine can interfere with bilirubin conjugation and increase the risk of jaundice in newborns, particularly in the first few months of life when their liver enzyme systems are still maturing. Studies on oral berberine have documented passage into breast milk, and while topical absorption is lower, the theoretical risk to breastfed infants exists. Additionally, berberine can affect the infant's gut microbiome and glucose regulation. Pediatricians and lactation consultants generally recommend avoiding berberine-containing products while breastfeeding, particularly in the first 3-4 months when infant jaundice risk is highest. The AAP has raised concerns about herbal products containing berberine during lactation. Given safer alternatives exist for antimicrobial and anti-inflammatory benefits, most healthcare providers advise postponing use until after weaning.
Hydrastis Canadensis Extract and postpartum
Safe to Use
- Common allergen
For postpartum women who are not breastfeeding, goldenseal extract presents fewer concerns. The antimicrobial and anti-inflammatory properties may be beneficial for skin healing and recovery, though safer alternatives with more established safety profiles exist. The main consideration is potential for allergic contact dermatitis, which can occur with botanical extracts. Women with sensitive postpartum skin should patch test before use. There are no specific hormonal concerns for non-breastfeeding postpartum use.
Hydrastis Canadensis Extract and trying to conceive
Caution Advised
- Fertility effects
- Hormone disruptor
For women trying to conceive, goldenseal extract raises concerns similar to early pregnancy. Berberine has been shown to affect hormonal pathways and uterine environment, potentially impacting implantation. Some studies suggest berberine may affect endometrial receptivity. While evidence is primarily from oral consumption studies, the conservative approach is to avoid berberine-containing products when trying to conceive, particularly given the uncertainty around timing of conception. Many fertility specialists recommend discontinuing use during the TTC period as a precautionary measure.
Hydrastis Canadensis Extract and PCOS
Caution Advised
- Affects insulin
- Interferes with hormones
Hydrastis Canadensis Extract contains berberine, which has documented effects on insulin sensitivity and glucose metabolism. Interestingly, oral berberine supplements have been studied for PCOS management due to insulin-sensitizing effects similar to metformin. However, topical use presents uncertain benefits and potential concerns. While berberine's insulin-sensitizing properties might seem beneficial, topical absorption provides unpredictable dosing that could interfere with prescribed PCOS medications like metformin. The compound may also affect sex hormone-binding globulin levels and androgen metabolism, though data on topical application is limited. For women with PCOS taking metformin or other medications affecting glucose metabolism, the unpredictable systemic absorption from topical products makes this ingredient less ideal. Dermatologists treating PCOS patients typically prefer ingredients with more predictable effects and no potential medication interactions.
Hydrastis Canadensis Extract and general use
Safe to Use
- Common allergen
For the general non-pregnant, non-breastfeeding population, goldenseal extract in topical cosmetics presents relatively low risk. The antimicrobial and anti-inflammatory properties can benefit acne-prone or inflamed skin. The primary concern for general users is potential allergic contact dermatitis. Some individuals may experience skin irritation or sensitivity to the alkaloid compounds. Those taking medications metabolized by CYP3A4 or CYP2D6 enzymes should be aware that topical berberine could theoretically affect drug metabolism, though this is more relevant to oral consumption. Patch testing is recommended for first-time users, particularly those with sensitive skin or known sensitivities to botanical extracts. Overall, the ingredient has a reasonable safety profile for short-term cosmetic use in healthy adults.
Everything else flagged for the same profiles
Related ingredients
Ingredients suggested in place of Hydrastis Canadensis Extract, each one with its own page here.
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store